Bio-Key Financial Statements From 2010 to 2022

BKYI
 Stock
  

USD 1.01  0.04  3.81%   

Bio-Key Intl financial statements provide useful quarterly and yearly information to potential Bio-Key Intl investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bio-Key Intl financial statements helps investors assess Bio-Key Intl's valuation, profitability, and current liquidity needs.
Bio-Key Intl does not presently have any fundamental signals for analysis.
.
  
Check Bio-Key Intl financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio-Key main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Bio-Key financial statements analysis is a perfect complement when working with Bio-Key Intl Valuation or Volatility modules. It can also supplement Bio-Key Intl's financial leverage analysis and stock options assessment as well as various Bio-Key Intl Technical models . Continue to the analysis of Bio-Key Intl Correlation against competitors.

Bio-Key Total Debt Analysis

Bio-Key Intl's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Total Debt 
 = 
Bonds 
+  
Notes 
More About Total Debt | All Equity Analysis

Current Bio-Key Intl Total Debt

    
  715.87 K  
Most of Bio-Key Intl's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio-Key Intl is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Based on the latest financial disclosure, Bio-Key Intl has a Total Debt of 715.87 K. This is 99.96% lower than that of the Industrials sector and 99.92% lower than that of the Security & Protection Services industry. The total debt for all United States stocks is 99.99% higher than that of the company.

Bio-Key Intl Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bio-Key Intl's current stock value. Our valuation model uses many indicators to compare Bio-Key Intl value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio-Key Intl competition to find correlations between indicators driving Bio-Key Intl's intrinsic value. More Info.
Bio-Key Intl is rated third in cash flow from operations category among related companies. It is rated third in debt to equity category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio-Key Intl by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio-Key Intl's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio-Key Intl's earnings, one of the primary drivers of an investment's value.

About Bio-Key Intl Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bio-Key Intl income statement, its balance sheet, and the statement of cash flows. Bio-Key Intl investors use historical funamental indicators, such as Bio-Key Intl's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio-Key Intl investors may use each financial statement separately, they are all related. The changes in Bio-Key Intl's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio-Key Intl's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bio-Key Intl Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bio-Key Intl. Please read more on our technical analysis and fundamental analysis pages.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bio-Key Intl without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Pair Trading with Bio-Key Intl

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio-Key Intl position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio-Key Intl will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bio-Key Intl

+0.62LUMNCenturylink Sell-off TrendPairCorr
+0.65DNAGinkgo Bioworks Hldgs Downward RallyPairCorr

Moving against Bio-Key Intl

-0.77GEOGeo Group Normal TradingPairCorr
-0.59JPMJP Morgan Chase Fiscal Year End 13th of January 2023 PairCorr
The ability to find closely correlated positions to Bio-Key Intl could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio-Key Intl when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio-Key Intl - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio-Key Intl to buy it.
The correlation of Bio-Key Intl is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio-Key Intl moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio-Key Intl moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio-Key Intl can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to the analysis of Bio-Key Intl Correlation against competitors. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for analysis

When running Bio-Key Intl price analysis, check to measure Bio-Key Intl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Key Intl is operating at the current time. Most of Bio-Key Intl's value examination focuses on studying past and present price action to predict the probability of Bio-Key Intl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bio-Key Intl's price. Additionally, you may evaluate how the addition of Bio-Key Intl to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Bio-Key Intl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio-Key Intl. If investors know Bio-Key will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio-Key Intl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.9 M
Quarterly Revenue Growth YOY
0.058
Return On Assets
(0.24) 
Return On Equity
(0.50) 
The market value of Bio-Key Intl is measured differently than its book value, which is the value of Bio-Key that is recorded on the company's balance sheet. Investors also form their own opinion of Bio-Key Intl's value that differs from its market value or its book value, called intrinsic value, which is Bio-Key Intl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio-Key Intl's market value can be influenced by many factors that don't directly affect Bio-Key Intl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio-Key Intl's value and its price as these two are different measures arrived at by different means. Investors typically determine Bio-Key Intl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio-Key Intl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.